Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY-NC-ND 4.0Genome Biology

Mapping lineage and functional diversity of the mammary epithelium in women at high risk of breast cancer

1 more authors
4 affiliations
  1. 1Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C1 Canada
  2. 2Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7 Canada
  3. 3Department of Cell and Systems Biology, University of Toronto, Toronto, ON M5S 1A8 Canada
  4. 4Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8 Canada

Abstract

Background: Breast cancer risk is shaped by the vast heterogeneity of mammary epithelial cells, comprising basal, luminal progenitor, and mature luminal populations. While transcriptional variation among these lineages has been extensively studied, protein-level features—particularly in high-risk women—remain underexplored, limiting insight into early cellular and molecular determinants of susceptibility. Moreover, little is known about how clinical covariates influence clonogenic capacity, proteomic states, and epithelial proportions.

Results: We combine low-input proteomics with functional clonogenic assays to profile mammary epithelial cell subpopulations from a cohort of 22 breast tissues encompassing different germline mutation backgrounds, parity status and age. We quantify 5,555 proteins and observed marked inter-donor variation in epithelial composition, proteomic programs, and colony-forming capacity. Multivariable modeling reveals that clinical covariates—including age, parity, and germline mutation status—modulate both global proteomic architecture and lineage-specific pathway activity. Parity is associated with reduced basal cell abundance, altered luminal progenitor and mature luminal proteomes, and changes in clonogenicity. Pathway analyses identify both conserved and lineage-restricted responses to shared risk factors. Projection of clonogenic signatures onto METABRIC and TCGA tumors further links functional programs to tumor subtypes and molecular phenotypes.

Conclusions: This study provides the most comprehensive proteomic atlas of cell-type resolved diversity in the high-risk breast to date. By defining how clinical covariates shape epithelial composition and molecular state, it clarifies key sources of biological variability that challenge controlled study design and offers a resource for improving mechanistic insight, risk assessment, and prevention strategies.

Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s13059-026-04243-3.

Related

  1. CDH1 loss remodels gene expression and lineage identity in human mammary epithelial cells
    Maggie Musick, Chinasa A. Ufondu, Carmen E. Rowland +12
    PLOS GeneticsPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCell biologyPLOSPMC
  2. Evaluation of Functional Activity of Ciliated Epithelium in Patients with Primary Ciliary Dyskinesia
    Tatiana Kyian, Anna Demchenko, Olga Solovova +7
    DiagnosticsPeer-reviewedCC BYFull textGeneral medicineDOAJ
  3. Spatial mapping of loco regional recurrences and disease related outcomes in breast cancer patients with Internal Mammary Node (IMN) positivity at presentation treated with a curative intent using moderately hypo-fractionated radiotherapy
    D. Chowdhury, S. Chatterjee, S. Chakraborty +2
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  4. Whole-genome sequencing analysis of phylogenetic relationships and lineage diversity of Mycobacterium tuberculosis in Western Kenya
    Susan Musau, Eleanor I. Lamont, Victor Moses Musyoki +9
    Frontiers in MicrobiologyPeer-reviewedCC BY 4.0Full textInfectious diseaseCrossrefEurope PMC
  5. PIEZO1 Is a Contextual Mechanosensor and Its Depletion in Scx-Lineage Cells Accelerates Structural and Functional Recovery.
    Nicole A Chittim, Maja Wolleb, Maya Ben-Yehuda Greenwald +2
    FASEB journal : official publication of the Federation of American Societies for Experimental BiologyPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
BibTeX
@article{waas2026mapping,
  title = {{Mapping lineage and functional diversity of the mammary epithelium in women at high risk of breast cancer}},
  author = {Matthew Waas and Bowen Zhang and Meinusha Govindarajan and Pirashaanthy Tharmapalan and Abhijith Kuttanamkuzhi and Olivia Drummond Guy and Denise Muganzi and Hui Fang and Michael Woolman and Hal K. Berman and Paul D. Waterhouse and Rama Khokha and Thomas Kislinger},
  journal = {Genome Biology},
  year = {2026},
  month = aug,
  doi = {10.1186/s13059-026-04243-3},
  url = {https://doi.org/10.1186/s13059-026-04243-3},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Mapping lineage and functional diversity of the mammary epithelium in women at high risk of breast cancer
AU  - Matthew Waas
AU  - Bowen Zhang
AU  - Meinusha Govindarajan
AU  - Pirashaanthy Tharmapalan
AU  - Abhijith Kuttanamkuzhi
AU  - Olivia Drummond Guy
AU  - Denise Muganzi
AU  - Hui Fang
AU  - Michael Woolman
AU  - Hal K. Berman
AU  - Paul D. Waterhouse
AU  - Rama Khokha
AU  - Thomas Kislinger
PY  - 2026
DA  - 2026/08/14
JO  - Genome Biology
DO  - 10.1186/s13059-026-04243-3
UR  - https://doi.org/10.1186/s13059-026-04243-3
AB  - Background: Breast cancer risk is shaped by the vast heterogeneity of mammary epithelial cells, comprising basal, luminal progenitor, and mature luminal populations. While transcriptional variation among these lineages has been extensively studied, protein-level features—particularly in high-risk women—remain underexplored, limiting insight into early cellular and molecular determinants of susceptibility. Moreover, little is known about how clinical covariates influence clonogenic capacity, proteomic states, and epithelial proportions.  Results: We combine low-input proteomics with functional clonogenic assays to profile mammary epithelial cell subpopulations from a cohort of 22 breast tissues encompassing different germline mutation backgrounds, parity status and age. We quantify 5,555 proteins and observed marked inter-donor variation in epithelial composition, proteomic programs, and colony-forming capacity. Multivariable modeling reveals that clinical covariates—including age, parity, and germline mutation status—modulate both global proteomic architecture and lineage-specific pathway activity. Parity is associated with reduced basal cell abundance, altered luminal progenitor and mature luminal proteomes, and changes in clonogenicity. Pathway analyses identify both conserved and lineage-restricted responses to shared risk factors. Projection of clonogenic signatures onto METABRIC and TCGA tumors further links functional programs to tumor subtypes and molecular phenotypes.  Conclusions: This study provides the most comprehensive proteomic atlas of cell-type resolved diversity in the high-risk breast to date. By defining how clinical covariates shape epithelial composition and molecular state, it clarifies key sources of biological variability that challenge controlled study design and offers a resource for improving mechanistic insight, risk assessment, and prevention strategies.  Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s13059-026-04243-3.
SN  - 1474-7596
SN  - 1474-760X
ER  -